Shopping Cart 0
Cart Subtotal
AED 0

Multiple Myeloma Research Foundation Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Multiple Myeloma Research Foundation Inc (MMRF) is a non-profit foundation that develops advanced multiple myeloma treatments. The foundation provides end-to-end solutions for drug discovery and development targeting multiple myeloma. It provides clinical trails such as molecularly targeted therapies, noval therapies, and immune therapies. MMRF's offers educational programs for people suffering from myeloma. The foundation also provides funded grants for academic researchers and coMMpass study. It partners with bio-technology and pharmaceutical, academia, and the cancer community industries. MMRF is headquartered in Norwalk, Connecticut, the US.

Multiple Myeloma Research Foundation Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Multiple Myeloma Research Foundation Inc, Medical Devices Deals, 2012 to YTD 2018 9

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Multiple Myeloma Research Foundation Enters into Agreement with Memorial Sloan Kettering Cancer Center 11

Multiple Myeloma Research Foundation Partners with University of Torino and Adaptive Biotech 12

Inflection Biosciences Enters into Agreement with Multiple Myeloma Research Foundation 13

GNS Healthcare Partners with Multiple Myeloma Research Foundation 14

Multiple Myeloma Research Foundation Inc-Key Competitors 15

Multiple Myeloma Research Foundation Inc-Key Employees 16

Multiple Myeloma Research Foundation Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Government and Public Interest 18

May 15, 2018: Multiple Myeloma Research Foundation (MMRF) Awards Grants to Young Researchers To Advance Understanding of Myeloma Disease Biology and Drive Precision Medicine 18

Mar 27, 2018: Multiple Myeloma Research Foundation (MMRF) Awards USD 7 Million to Advance Cutting-edge Immunotherapy Initiative 20

Nov 22, 2017: Analysis of Large-Scale Multiple Myeloma Data by USC Translational Genomics Scientists Reveals Mutation Differences Between African American and Caucasian Patients 21

Product News 22

Dec 12, 2017: GNS Healthcare Uses Causal AI to Discover Which Multiple Myeloma Patients Will Have Progression Free Survival Benefit from Stem Cell Treatments 22

Other Significant Developments 23

Aug 27, 2018: MMRF Announces 2018 Endurance Run/Relay to Advance Multiple Myeloma Research to Improve the Lives of Patients 23

Jun 29, 2017: Multiple Myeloma Research Foundation (MMRF) Announces USD 15 Million Investment in Immunotherapy Initiative 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Multiple Myeloma Research Foundation Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Key Facts 2

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Multiple Myeloma Research Foundation Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Multiple Myeloma Research Foundation Inc, Medical Devices Deals, 2012 to YTD 2018 9

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Multiple Myeloma Research Foundation Enters into Agreement with Memorial Sloan Kettering Cancer Center 11

Multiple Myeloma Research Foundation Partners with University of Torino and Adaptive Biotech 12

Inflection Biosciences Enters into Agreement with Multiple Myeloma Research Foundation 13

GNS Healthcare Partners with Multiple Myeloma Research Foundation 14

Multiple Myeloma Research Foundation Inc, Key Competitors 15

Multiple Myeloma Research Foundation Inc, Key Employees 16

Multiple Myeloma Research Foundation Inc, Subsidiaries 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Multiple Myeloma Research Foundation Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Multiple Myeloma Research Foundation Inc (MMRF) is a non-profit foundation that develops advanced multiple myeloma treatments. The foundation provides end-to-end solutions for drug discovery and development targeting multiple myeloma. It provides clinical trails such as molecularly targeted therapies, noval therapies, and immune therapies. MMRF's offers educational programs for people suffering from myeloma. The foundation also provides funded grants for academic researchers and coMMpass study. It partners with bio-technology and pharmaceutical, academia, and the cancer community industries. MMRF is headquartered in Norwalk, Connecticut, the US.

Multiple Myeloma Research Foundation Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Multiple Myeloma Research Foundation Inc, Medical Devices Deals, 2012 to YTD 2018 9

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Multiple Myeloma Research Foundation Enters into Agreement with Memorial Sloan Kettering Cancer Center 11

Multiple Myeloma Research Foundation Partners with University of Torino and Adaptive Biotech 12

Inflection Biosciences Enters into Agreement with Multiple Myeloma Research Foundation 13

GNS Healthcare Partners with Multiple Myeloma Research Foundation 14

Multiple Myeloma Research Foundation Inc-Key Competitors 15

Multiple Myeloma Research Foundation Inc-Key Employees 16

Multiple Myeloma Research Foundation Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Government and Public Interest 18

May 15, 2018: Multiple Myeloma Research Foundation (MMRF) Awards Grants to Young Researchers To Advance Understanding of Myeloma Disease Biology and Drive Precision Medicine 18

Mar 27, 2018: Multiple Myeloma Research Foundation (MMRF) Awards USD 7 Million to Advance Cutting-edge Immunotherapy Initiative 20

Nov 22, 2017: Analysis of Large-Scale Multiple Myeloma Data by USC Translational Genomics Scientists Reveals Mutation Differences Between African American and Caucasian Patients 21

Product News 22

Dec 12, 2017: GNS Healthcare Uses Causal AI to Discover Which Multiple Myeloma Patients Will Have Progression Free Survival Benefit from Stem Cell Treatments 22

Other Significant Developments 23

Aug 27, 2018: MMRF Announces 2018 Endurance Run/Relay to Advance Multiple Myeloma Research to Improve the Lives of Patients 23

Jun 29, 2017: Multiple Myeloma Research Foundation (MMRF) Announces USD 15 Million Investment in Immunotherapy Initiative 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Multiple Myeloma Research Foundation Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Key Facts 2

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Multiple Myeloma Research Foundation Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Multiple Myeloma Research Foundation Inc, Medical Devices Deals, 2012 to YTD 2018 9

Multiple Myeloma Research Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Multiple Myeloma Research Foundation Enters into Agreement with Memorial Sloan Kettering Cancer Center 11

Multiple Myeloma Research Foundation Partners with University of Torino and Adaptive Biotech 12

Inflection Biosciences Enters into Agreement with Multiple Myeloma Research Foundation 13

GNS Healthcare Partners with Multiple Myeloma Research Foundation 14

Multiple Myeloma Research Foundation Inc, Key Competitors 15

Multiple Myeloma Research Foundation Inc, Key Employees 16

Multiple Myeloma Research Foundation Inc, Subsidiaries 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Multiple Myeloma Research Foundation Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.